The findings revealed that EZH2 levels were significantly correlated with clinicopathological characteristics including TNM stage, lymph node metastasis, muscle invasion, and tumor size (Tables 1, 2). Here, EZH2 is linked to metastatic malignant neoplasm in the lymph nodes.